Skip to main content

Month: May 2020

Blackhawk’s Initial Order of 1,000 COVID-19 Antibody Testing Kits Delivered to Healthcare Clinic in Rocklin, California – 5 Days After Initial Order Was Submitted

VANCOUVER, British Columbia, May 11, 2020 (GLOBE NEWSWIRE) — Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ; US-OTC:BLRZF) (the “Corporation” or “Blackhawk”), is pleased to announce that after submitting its initial order on May 1, 2020 for 1,000 Innovita manufactured COVID-19 antibody testing kits, the Company can confirm that the kits arrived and were delivered to the healthcare clinic in Rocklin, California on May 6, 2020. These testing kits are being immediately distributed to healthcare professionals in the area.“This is the start we were hoping for,” said Frederick Pels, CEO of Blackhawk. “Showing that we can deliver these kits in such a short timeframe puts us vastly ahead of others in the space. The clinic is ecstatic, and we have begun negotiations on additional larger orders. A 5-day delivery time is phenomenal and I’m...

Continue reading

Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series

GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory Glenn, M.D., President of Research and Development, will present progress of NVX-CoV2373, Novavax’ coronavirus vaccine candidate, on Wednesday, May 13, 2020 as part of the World Vaccine Congress’ COVID-19 webinar series. Dr. Glenn joins a distinguished group of global public health, epidemiology, regulatory and industry leaders in sharing expertise and information related to the SARS-Cov-2 virus, as well as ongoing efforts to develop vaccines to address the global health pandemic.Dr. Glenn’s presentation will be followed by a live Q&A discussion. Webinar details are as follows:Topic:                          Recombinant...

Continue reading

DELFINGEN Industry : Mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 5 juin 2020

MISE A DISPOSITION DE DOCUMENTSAnteuil, le 11 mai 2020 DELFINGEN Industry annonce ce jour avoir mis à disposition du public les documents préparatoires à l’Assemblée Générale Mixte du 5 juin 2020.DELFINGEN, un leader mondial dans les solutions de protection et de cheminementdes réseaux électriques et fluides embarqués.EURONEXT GROWTH Paris – Code ISIN : FR 0000054132 – Mnémonique : ALDELContact : M. Christophe CLERC : +33 (0)3.81.90.73.00www.delfingen.com  Pièce jointeDELFINGEN Industry – Mise a disposition documents AG 2020

Continue reading

DELFINGEN Industry : Assemblée Générale Mixte à huis clos – 5 juin 2020

INFORMATION ACTIONNAIRES   Anteuil, le 11 mai 2020Cher (Chère) Actionnaire,Cependant, nous vous invitons à exercer vos droits d’actionnaires en participant au vote des résolutions. Nous vous invitons à vous référer à la rubrique dédiée de notre site internet : www.delfingen.com, rubrique Finance > Espace actionnaires.  DELFINGEN, un leader mondial dans les solutions de protection et de cheminementdes réseaux électriques et fluides embarqués.EURONEXT GROWTH Paris – Code ISIN : FR 0000054132 – Mnémonique : ALDELContact : M. Christophe CLERC : +33 (0)3.81.90.73.00www.delfingen.comPièce jointeDELFINGEN Industry – Information Actionnaires AG 2020 huis clos

Continue reading

JCDecaux remporte le contrat du mobilier urbain publicitaire de Bogota (Colombie) pour 15 ans

JCDecaux remporte le contrat du mobilier urbain publicitaire de Bogota (Colombie) pour 15 ansParis, le 11 mai 2020 – JCDecaux SA (Euronext Paris : DEC), numéro un mondial de la communication extérieure, annonce aujourd’hui que sa filiale colombienne (détenue à 75 % par JCDecaux et à 25 % par Caracol Television) a remporté, à la suite d’un appel d’offres, le contrat du mobilier urbain publicitaire de la capitale de la Colombie, Bogota (la plus grande ville du pays avec 11 millions d’habitants), pour 15 ans.Ce contrat porte sur la conception, l’installation, l’entretien et la maintenance de plus de 6 000 mobiliers urbains apportant un service public : abribus, mobiliers d’information digitaux destinés à renforcer l’attractivité culturelle et touristique de Bogota – grâce à des plans, informations, calculs d’itinéraires, etc –...

Continue reading

JCDecaux wins a 15-year street furniture advertising contract in Bogota – Colombia

JCDecaux wins a 15-year street furniture advertising contract in Bogota – ColombiaParis, May 11th, 2020 – JCDecaux SA (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announced today that, following a competitive tender, its Colombian subsidiary  75% owned by JCDecaux and 25% owned by Caracol Television, has won the 15-year street furniture contract for the Colombian capital, Bogota (the largest city in the country, with 11 million inhabitants).This contract covers the design, installation, operation and maintenance of more than 6,000 street furniture displays that provide a public service: bus shelters, smart digital city information panels to enhance the cultural and tourist appeal of Bogota – with maps, information, local route guidance, etc – and bus stops, all tailored to beautify the...

Continue reading

Eurobio Scientific: Eurobio Scientific’s proprietary PCR test confirmed as part of the fight against COVID-19

Eurobio Scientific’s proprietary PCR test confirmedas part of the fight against COVID-19Paris, May 11, 2020 – 5 :45 pmEurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in the field of specialty in vitro medical diagnostics, announces today that its proprietary test EBX 041 SARS COV-2 for the detection of the genome of the virus responsible for the Covid-19 disease, under license from the Institut Pasteur and CE marked, is part of the list of “Devices CE marked or validated by a CNR, reimbursed by the French national health insurance ”as published by the French administration1 on May 5, 2020.A proprietary test designed, developed and manufactured in FranceEBX 041 SARS COV-2 is a multiplexed real-time PCR test directly usable on a large number of open thermocycling instruments, which can be found...

Continue reading

Eurobio Scientific : Le test propriétaire PCR d’Eurobio Scientific confirmé dans le cadre de la lutte contre COVID-19

Le test propriétaire PCR d’Eurobio Scientific confirmédans le cadre de la lutte contre COVID-19Paris, le 11 mai 2020 – 17h45Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, précise aujourd’hui que son test propriétaire EBX 041 SARS COV-2 pour la détection du génome du virus responsable de la maladie Covid-19, sous licence de l’Institut Pasteur et marqué CE, fait partie de la liste des « Dispositifs marqués CE ou validés par un CNR, pris en charge par l’assurance maladie » telle que publiée par l’Administration1 en date du 5 mai 2020.Un test propriétaire conçu, developpé et fabriqué en FranceEBX 041 SARS COV-2 est un test de PCR en temps réel multiplexé directement utilisable sur un grand nombre d’instruments thermocycleurs ouverts, présents dans les laboratoires...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 11 May 2020

Rovio Entertainment Corporation – Repurchase of own shares on 11 May 2020Rovio Entertainment Corporation                 STOCK EXCHANGE RELEASE                   11 May 2020 AT 18:45 EETIn the Nasdaq HelsinkiDate                                                                                11 May 2020Exchange transaction                                                       BuyShare trading code                                                           ROVIOAmount, shares                                                                56565Average price/share, EUR                                                 5,515271Total cost, EUR                                                                311971,30ROVIO now holds a total of 5 634 683 own shares (ROVIO) including the shares repurchased on 11 May 2020.On behalf of Rovio Entertainment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.